SOLID TUMOR MALIGNANCY

Clinical trials for SOLID TUMOR MALIGNANCY explained in plain language.

Never miss a new study

Get alerted when new SOLID TUMOR MALIGNANCY trials appear

Sign up with your email to follow new studies for SOLID TUMOR MALIGNANCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 2 Terminated 1

Targeted drug tested for hard-to-treat cancers based on genetic fingerprint

Disease control Terminated

This study tested whether the drug pemigatinib could help control advanced solid tumors that had specific genetic changes (FGFR mutations or fusions) and had stopped responding to other treatments. It involved 111 adults whose cancer had spread or could not be removed by surgery.…

Matched conditions: SOLID TUMOR MALIGNANCY

Phase: PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control

Last updated Mar 09, 2026 14:26 UTC

SOLID TUMOR MALIGNANCY

Get alerted when new SOLID TUMOR MALIGNANCY trials appear

Targeted drug tested for hard-to-treat cancers based on genetic fingerprint